HRT FINANCIAL LP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2021$134,000
-64.5%
13,728
-75.5%
0.00%
-66.7%
Q2 2021$377,000
+209.0%
56,101
+314.9%
0.00%
+200.0%
Q1 2021$122,000
+106.8%
13,520
+14.2%
0.00%
-50.0%
Q3 2020$59,000
-42.2%
11,837
-6.7%
0.00%
-33.3%
Q2 2020$102,000
+209.1%
12,692
-3.7%
0.00%
-40.0%
Q4 2018$33,00013,1740.01%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 4,133,464$45,592,0005.54%
Stonepine Capital Management, LLC 747,863$8,249,0004.45%
JW Asset Management, LLC 444,439$4,902,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$40,320,0002.15%
ARMISTICE CAPITAL, LLC 1,150,000$12,685,0001.62%
FALCON POINT CAPITAL, LLC 855,101$9,432,0001.27%
Perceptive Advisors 1,429,114$15,763,0000.79%
KNOTT DAVID M 126,463$1,395,0000.58%
HEARTLAND ADVISORS INC 700,000$7,721,0000.50%
Sio Capital Management, LLC 91,413$1,008,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders